article thumbnail

Bayer and Evotec link to develop precision cardiology therapeutics

Pharmaceutical Technology

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).

article thumbnail

Light-activated ink developed to remotely control cardiac tissue to repair the heart

Medical Xpress

Researchers from Mass General Brigham and collaborating institutions have developed a non-invasive approach to manipulate cardiac tissue activity by using light to stimulate an innovative ink incorporated into bioprinted tissue. Their goal is to develop a technique that can be used to repair the heart.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NBA Legend Pau Gasol Invests in AI Cardiology Company Idoven

XTalks

Los Angeles Lakers and Spain’s basketball legend Pau Gasol is investing in artificial intelligence (AI) company Idoven , which is developing an AI-powered cardiology service platform. Gasol joins Iker Casillas, Spain’s winning World Cup goalkeeper, as the second athlete to invest in the AI cardiology company.

article thumbnail

UK regulator backs Amarin’s cardiology drug Vazkepa

pharmaphorum

Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The post UK regulator backs Amarin’s cardiology drug Vazkepa appeared first on. Icosapent ethyl also demonstrated a 26% relative risk reduction and a 3.6%

article thumbnail

Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development

FDA Law Blog

Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.

article thumbnail

Cardiology collaboration advances machine learning predictions for AFib after stroke

Medical Xpress

A team of artificial intelligence engineers, in collaboration with a team of physicians from Penn State Heart and Vascular Institute, is working to develop novel algorithms for point-of-care, in-house use and for technology licensing.

article thumbnail

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

Outsourcing Pharma

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.